Information about Duaklir Genuair
Duaklir Genuair is a combination inhaler containing aclidinium bromide and formoterol fumarate, designed for the management of chronic obstructive pulmonary disease (COPD). This medication is administered via a dry powder inhaler (DPI) and works by relaxing the airways to improve airflow and reduce breathing difficulties.
Product Highlights
- Specifically indicated for the maintenance treatment of patients with COPD to improve lung function and alleviate symptoms.
- Combines a long-acting muscarinic antagonist (LAMA) and a long-acting beta-agonist (LABA).
Key Ingredient
Key Benefits
- Helps enhance airflow and reduces the frequency of exacerbations.
- Relieves symptoms like shortness of breath and wheezing.
- Typically administered twice daily for optimal control of COPD symptoms.
Direction of Use
- Use as prescribed by a healthcare professional. The typical dosage is one inhalation two times a day.
- Follow instructions for loading the dose before inhalation.
- Inhale deeply and forcefully to ensure medication reaches the lungs.
Safety Concerns
- May include headache, throat irritation, cough, or nausea.
- Potential for paradoxical bronchospasm; seek immediate medical attention if breathing worsens.
- Monitor for increased heart rate or palpitations.
Avoid Duaklir Genuair If
- If you have a known allergy to aclidinium, formoterol, or any of the inhaler components.
- Not recommended for asthma management.
- qIf you have a history of severe cardiovascular conditions, consult your healthcare provider before use.
